201 related articles for article (PubMed ID: 20147252)
41. Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.
Zonari E; Desantis G; Petrillo C; Boccalatte FE; Lidonnici MR; Kajaste-Rudnitski A; Aiuti A; Ferrari G; Naldini L; Gentner B
Stem Cell Reports; 2017 Apr; 8(4):977-990. PubMed ID: 28330619
[TBL] [Abstract][Full Text] [Related]
42. High-efficiency lentiviral transduction of primary human CD34⁺ hematopoietic cells with low-dose viral inocula.
Park SW; Pyo CW; Choi SY
Biotechnol Lett; 2015 Feb; 37(2):281-8. PubMed ID: 25257593
[TBL] [Abstract][Full Text] [Related]
43. Lentiviral gene transduction of mouse and human hematopoietic stem cells.
van Til NP; Wagemaker G
Methods Mol Biol; 2014; 1185():311-9. PubMed ID: 25062638
[TBL] [Abstract][Full Text] [Related]
44. Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene.
Leuci V; Gammaitoni L; Capellero S; Sangiolo D; Mesuraca M; Bond HM; Migliardi G; Cammarata C; Aglietta M; Morrone G; Piacibello W
Stem Cells; 2009 Nov; 27(11):2815-23. PubMed ID: 19785032
[TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
[TBL] [Abstract][Full Text] [Related]
46. Forward RNAi screens in primary human hematopoietic stem/progenitor cells.
Ali N; Karlsson C; Aspling M; Hu G; Hacohen N; Scadden DT; Larsson J
Blood; 2009 Apr; 113(16):3690-5. PubMed ID: 19188664
[TBL] [Abstract][Full Text] [Related]
47. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.
Salmon P; Kindler V; Ducrey O; Chapuis B; Zubler RH; Trono D
Blood; 2000 Nov; 96(10):3392-8. PubMed ID: 11071633
[TBL] [Abstract][Full Text] [Related]
48. Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters.
Canté-Barrett K; Mendes RD; Smits WK; van Helsdingen-van Wijk YM; Pieters R; Meijerink JP
BMC Res Notes; 2016 Jun; 9():312. PubMed ID: 27306375
[TBL] [Abstract][Full Text] [Related]
49. ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells.
Davis BM; Humeau L; Slepushkin V; Binder G; Korshalla L; Ni Y; Ogunjimi EO; Chang LF; Lu X; Dropulic B
Blood; 2004 Jul; 104(2):364-73. PubMed ID: 15059841
[TBL] [Abstract][Full Text] [Related]
50. Lentiviral Infection of Mouse Bone Marrow Cells for Hematopoietic Stem Cell Transplantation.
Chen C; Guderyon MJ; Ge G; Clark RA; Li S
Methods Mol Biol; 2019; 1919():205-213. PubMed ID: 30656632
[TBL] [Abstract][Full Text] [Related]
51. Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors.
Leuci V; Mesiano G; Gammaitoni L; Cammarata C; Capellero S; Todorovic M; Jordaney N; Circosta P; Elia A; Lesnikova M; Georges GE; Piacibello W; Fagioli F; Cignetti A; Aglietta M; Sangiolo D
J Biotechnol; 2011 Dec; 156(3):218-26. PubMed ID: 21933686
[TBL] [Abstract][Full Text] [Related]
52. Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.
Greene MR; Lockey T; Mehta PK; Kim YS; Eldridge PW; Gray JT; Sorrentino BP
Hum Gene Ther Methods; 2012 Oct; 23(5):297-308. PubMed ID: 23075105
[TBL] [Abstract][Full Text] [Related]
53. Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD.
Abraham A; Kim YS; Zhao H; Humphries K; Persons DA
PLoS One; 2016; 11(1):e0147059. PubMed ID: 26761813
[TBL] [Abstract][Full Text] [Related]
54. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells.
Stier S; Cheng T; Forkert R; Lutz C; Dombkowski DM; Zhang JL; Scadden DT
Blood; 2003 Aug; 102(4):1260-6. PubMed ID: 12702511
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic gene editing in CD34
Diez B; Genovese P; Roman-Rodriguez FJ; Alvarez L; Schiroli G; Ugalde L; Rodriguez-Perales S; Sevilla J; Diaz de Heredia C; Holmes MC; Lombardo A; Naldini L; Bueren JA; Rio P
EMBO Mol Med; 2017 Nov; 9(11):1574-1588. PubMed ID: 28899930
[TBL] [Abstract][Full Text] [Related]
56. Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage.
Tonnelle C; Bardin F; Maroc C; Imbert AM; Campa F; Dalloul A; Schmitt C; Chabannon C
Blood; 2001 Nov; 98(9):2673-80. PubMed ID: 11675337
[TBL] [Abstract][Full Text] [Related]
57. In Vitro Erythroid Differentiation and Lentiviral Knockdown in Human CD34+ Cells from Umbilical Cord Blood.
Kovilakath A; Mohamad S; Hermes F; Wang SZ; Ginder GD; Lloyd JA
Methods Mol Biol; 2018; 1698():259-274. PubMed ID: 29076096
[TBL] [Abstract][Full Text] [Related]
58. One-Year Observation of the SCID-Repopulating Cell Activities of Human Cord Blood-Derived CD34-Positive and -Negative Hematopoietic Stem Cells.
Matsuoka Y; Sumide K; Sonoda Y
Stem Cell Rev Rep; 2019 Jun; 15(3):459-461. PubMed ID: 30982173
[No Abstract] [Full Text] [Related]
59. Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors.
Taher TE; Tulone C; Fatah R; D'Acquisto F; Gould DJ; Mageed RA
Gene Ther; 2008 Jul; 15(13):998-1006. PubMed ID: 18356817
[TBL] [Abstract][Full Text] [Related]
60. The Engraftment of Lentiviral Vector-Transduced Human CD34+ Cells into Humanized Mice.
Kim YS; Wielgosz M; Ryu B
Methods Mol Biol; 2019; 2005():91-100. PubMed ID: 31175648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
